Baicalein is considered to possess antitumor activity, which can effectively disrupt the proliferation, migration, and invasion of CRC cells and decrease the expression of epithelial-mesenchymal transition promoting factors including vimentin, Twist1, and Snail [56, 57]. The gene discussed is SNAI1; the disease is colorectal carcinoma.